Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析

◆英語タイトル:Regeneron Pharmaceuticals Inc (REGN) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME81628PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases. It develops products using its Trap and VelociSuite technology platforms, which include VelociGene, VelocImmune, VelociMouse, VelociMab, Veloci-Bi and other related technologies. The company operates manufacturing facilities in Rensselaer, New York and Limerick, Ireland. It also works in collaboration with strategic partners to develop, manufacture and commercialize its products. It sells its products to specialty pharmacies and distributors. The company and its subsidiaries operate in the US, Bermuda, the Netherlands, Ireland, Spain and the UK. Regeneron is headquartered in Tarrytown, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Regeneron Pharmaceuticals Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Regeneron Pharmaceuticals Inc Company Overview
Regeneron Pharmaceuticals Inc Company Snapshot
Regeneron Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
Regeneron Pharmaceuticals Inc – Pipeline Analysis Overview
Business Description
Regeneron Pharmaceuticals Inc – Key Facts
Regeneron Pharmaceuticals Inc – Major Products and Services
Regeneron Pharmaceuticals Inc Pipeline Products by Development Stage
Regeneron Pharmaceuticals Inc Pipeline Products Overview
DUPIXENT Pre-filled Syringe
DUPIXENT Pre-filled Syringe Product Overview
DUPIXENT Pre-filled Syringe – Adolescents
DUPIXENT Pre-filled Syringe – Adolescents Product Overview
DUPIXENT Pre-filled Syringe – Pediatric Atopic Dermatitis (6 mo-5 yr)
DUPIXENT Pre-filled Syringe – Pediatric Atopic Dermatitis (6 mo-5 yr) Product Overview
DUPIXENT Pre-filled Syringe – Pediatrics (6-11 years)
DUPIXENT Pre-filled Syringe – Pediatrics (6-11 years) Product Overview
Injectable Drug Delivery Device
Injectable Drug Delivery Device Product Overview
Regeneron Pharmaceuticals Inc – Key Competitors
Regeneron Pharmaceuticals Inc – Key Employees
Regeneron Pharmaceuticals Inc – Key Employee Biographies
Regeneron Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Regeneron Pharmaceuticals Inc, Recent Developments
Sep 05, 2020: Kaskela Law announces investigation of Regeneron Pharmaceuticals (Regn) and encourages long-term Regn stockholders to contact the firm
Jun 24, 2020: Kymab wins Supreme Court case against Regeneron
Jun 03, 2020: Kymab announces that the US Patent Trial and Appeal Board rejects a fifth request by Regeneron for invalidation of Kymab’s US patents
Apr 14, 2020: Kymab announces that the US Patent Trial and Appeal Board rejects requests for invalidation filed by Regeneron
Feb 08, 2020: EYLEA (aflibercept) injection reduced risk of developing vision-threatening events by 75% after two years in patients with diabetic retinopathy
Feb 06, 2020: Regeneron reports fourth quarter and full year 2019 financial and operating results
Jan 23, 2020: Bayer submits application to European Medicines Agency for pre-filled syringe to administer eye medication Eylea
Jan 08, 2020: Publication highlights Regeneron’s costimulatory bispecific antibodies, an emerging class of cancer immunotherapy
Dec 12, 2019: Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education
Nov 22, 2019: Regeneron’s Yancopoulos receives Columbia College’s Alexander Hamilton Award
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Regeneron Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
Regeneron Pharmaceuticals Inc Pipeline Products by Equipment Type
Regeneron Pharmaceuticals Inc Pipeline Products by Indication
Regeneron Pharmaceuticals Inc, Key Facts
Regeneron Pharmaceuticals Inc, Major Products and Services
Regeneron Pharmaceuticals Inc Number of Pipeline Products by Development Stage
Regeneron Pharmaceuticals Inc Pipeline Products Summary by Development Stage
DUPIXENT Pre-filled Syringe - Product Status
DUPIXENT Pre-filled Syringe - Product Description
DUPIXENT Pre-filled Syringe - Adolescents - Product Status
DUPIXENT Pre-filled Syringe - Adolescents - Product Description
DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Status
DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Description
DUPIXENT Pre-filled Syringe - Pediatrics (6-11 years) - Product Status
DUPIXENT Pre-filled Syringe - Pediatrics (6-11 years) - Product Description
Injectable Drug Delivery Device - Product Status
Injectable Drug Delivery Device - Product Description
Regeneron Pharmaceuticals Inc, Key Employees
Regeneron Pharmaceuticals Inc, Key Employee Biographies
Regeneron Pharmaceuticals Inc, Other Locations
Regeneron Pharmaceuticals Inc, Subsidiaries
Glossary

★海外企業調査レポート[Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CapeRay Medical (Pty) Ltd:製品パイプライン分析
    Summary CapeRay Medical (Pty) Ltd (CapeRay), formerly African Medical Imaging is a medical device company that offers imaging solutions. The company offers breast imaging devices. It offers aceso system to detect breast cancer with standard digital mammography. CapeRay’s aceso system is used for det …
  • Bloomberg L.P.:戦略・SWOT・企業財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lukoil Oil Co (LKOH)-エネルギー分野:企業M&A・提携分析
    Summary Lukoil Oil Company (Lukoil) is a vertically integrated oil and gas company, which carries out exploration and production of crude oil and natural gas. Lukoil has interest in properties across Russia, Azerbaijan, Kazakhstan, Uzbekistan, the Middle East, South America, Northern and Western Afr …
  • Protonex Technology Corporation:電力:M&Aディール及び事業提携情報
    Summary Protonex Technology Corporation (Protonex) is a fuel cell company, which carries out research, development and production of a wide range of power solutions. It principally offers advanced fuel cell power solutions for portable, remote and mobile applications. The company produces these prod …
  • The Royal Bank Of Scotland Group Plc:企業の戦略・SWOT・財務分析
    The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Sheridan Healthcare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sheridan Healthcare Inc (Sheridan Healthcare), a subsidiary of AmSurg Corp, is a healthcare service provider that offers physician services. The center offers office-based services in the areas of OBGYN, gynecology, gynecologic oncology, perinatology and pain management. It provides support, …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transport …
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BDO International Limited:企業の戦略・SWOT・財務分析
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mgm China Holdings Ltd
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Essential Energy:企業の戦略的SWOT分析
    Essential Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Iberia Lineas Aereas de Espana, SA:企業の戦略・SWOT・財務情報
    Iberia Lineas Aereas de Espana, SA - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas de Espana, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Societatea Nationala Nuclearelectrica SA (SNN):電力:M&Aディール及び事業提携情報
    Summary Societatea Nationala Nuclearelectrica SA (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nucle …
  • Edison SpA (EDNR):電力:M&Aディール及び事業提携情報
    Summary Edison SpA (Edison), a subsidiary of Electricite de France S.A., is an energy company that explores, produces, develops and sells natural gas and crude oil in the Mediterranean Basin. The company generates and sells electricity; and develops, stores, transports and sells gas in Italy. Edison …
  • Optiscan Imaging Limited (OIL):製品パイプライン分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • Future Consumer Ltd (FCONSUMER):企業の財務・戦略的SWOT分析
    Future Consumer Ltd (FCONSUMER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆